CAS No.:12108-13-3
Name: Methylcyclopentadienylmanganese tricarbonyl
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LCLo | inhalation | 223mg/m3/7H (223mg/m3) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
dog | LCLo | inhalation | 489mg/m3/2H (489mg/m3) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
dog | LDLo | intravenous | 10mg/kg (10mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
dog | LDLo | oral | 620mg/kg (620mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
guinea pig | LCLo | inhalation | 411mg/m3/7H (411mg/m3) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
guinea pig | LD50 | oral | 905mg/kg (905mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
mouse | LC50 | inhalation | 58600ug/m3/4H (58.6mg/m3) | Sangyo Igaku. Japanese Journal of Industrial Health. Vol. 20, Pg. 553, 1978. | |
mouse | LD50 | intraperitoneal | 152mg/kg (152mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Shikoku Igaku Zasshi. Shikoku Medical Journal. Vol. 34, Pg. 183, 1978. |
mouse | LD50 | oral | 34mg/kg (34mg/kg) | Nichidai Igaku Zasshi. Nihon University Medical Journal. Vol. 44, Pg. 173, 1985. | |
rabbit | LCLo | inhalation | 411mg/m3/7H (411mg/m3) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
rabbit | LD50 | intravenous | 6600ug/kg (6.6mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
rabbit | LD50 | oral | 95mg/kg (95mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
rabbit | LD50 | skin | 140mg/kg (140mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
American Industrial Hygiene Association Journal. Vol. 40, Pg. 164, 1979. |
rat | LC50 | inhalation | 76mg/m3/4H (76mg/m3) | SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
American Industrial Hygiene Association Journal. Vol. 40, Pg. 164, 1979. |
rat | LD50 | intraperitoneal | 12mg/kg (12mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BLOOD: HEMORRHAGE LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA |
Toxicology Letters. Vol. 39, Pg. 1, 1987. |
rat | LD50 | oral | 8mg/kg (8mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. | |
rat | LD50 | skin | 665mg/kg (665mg/kg) | "The Toxicology of Methylcyclopentadienyl Manganese Tricarbonyl," Witherup, S., et al., Cincinnati, OH, Univ. of Cincinnati, 1976Vol. -, Pg. -, 1976. |
Consensus Reports:
EPA Extremely Hazardous Substances List. Manganese and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.
SAFETY PROFILE:
Poison by ingestion, inhalation, skin contact, intravenous, and intraperitoneal routes. A skin irritant. When heated to decomposition it emits toxic fumes of CO. See also MANGANESE COMPOUNDS and CARBONYLS.
Hazard Codes: T
Risk Statements: 23/24/25-40
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed.
R40:Limited evidence of a carcinogenic effect.
Safety Statements: 23-26-36/37/39-45
S23:Do not breathe vapour.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 3281 6.1/PG 2
WGK Germany: 3
RTECS: OP1450000
TSCA: Yes
HazardClass: 6.1
PackingGroup: II
Standards and Recommendations:
OSHA PEL: TWA 0.2 mg(Mn)/m3 (skin)
ACGIH TLV: TWA 5 mg(Mn)/m3
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione